Spotlight on anti-CD20.

E Waubant1

  • 1UCSF MS Center, 350 Parnassus Street, Suite 908, San Francisco, California 94117, USA. Emmanuelle.Waubant@ucsf.edu

International MS Journal
|August 21, 2008
PubMed
Summary

B-cells play a significant role in multiple sclerosis (MS) pathogenesis. Targeting B-cells, like with rituximab, shows promise for treating MS and related CNS inflammatory diseases.